openPR Logo
Press release

2019-2027 Orphan Drugs Market In-depth Analysis by Active Ingredients, Disease, Appication profiling CELGENE CORPORATION, Novartis AG, Takeda Pharmaceuticals, Biogen, Bristol-Myers Squibb

07-04-2019 06:05 AM CET | Science & Education

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

"Global Orphan Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Orphan Drugs market with detailed market segmentation by active ingredients, disease, end user and geography.

Orphan Drugs Market to 2027 - Global Analysis and Forecasts by Active ingredients (Obinutuzumab, Lenalidomide, Brentuximab, Vedotin, Riociguat, Ofatumumab, Nelarabine, Bosutinib, Mannitol, Carglumic acid, Aztreonam, Histamine hydrochloride, Eliglustat, Cabozantinib, Ramucirumab, Decitabine, Defibrotide) ; Disease (Hodgkin lymphoma, Paroxysmal nocturnal hemoglobinuria, Chronic thromboembolic pulmonary hypertension (CTEPH) , Chronic lymphocytic leukemia, Chronic Myeloid Leukaemia, T-cell acute lymphoblastic leukemia (T-ALL) , Philadelphia chromosome positive chronic myelogenous leukaemia (Ph+ CML) , Cystic fibrosis (CF) , acute myeloid leukaemia, Multiple Myeloma, Isovaleric acidaemia, Gaucher disease type 1 (GD1) , Metastatic medullary thyroid carcinoma, Advanced gastric cancer or gastro-esophageal junction adenocarcinoma, Secondary Acute myeloid leukemia (AML) , Severe hepatic venoocclusive disease (VOD) / sinusoidal obstructive syndrome (SOS) ) ; End User (Hospitals, Ambulatory Surgical Centers)

Orphan Drugs are pharmaceutical drugs that remain commercially undeveloped. These are vaccines, medicine or in-vivo diagnostic agent, which are intended to treat, diagnose and prevent a rare disease.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00005799?utm_source=OpenPR&utm_medium=Simran

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Orphan Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Orphan Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Orphan Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Orphan Drugs market in these regions.

The report also includes the profiles of Orphan Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Top Players covered in this Report are F. Hoffmann-La Roche, Eli Lilly and Company, Alexion, CELGENE CORPORATION, Novartis AG, Takeda Pharmaceuticals Company Limited, Biogen, Bristol-Myers Squibb Company, Bayer AG, Sanofi

Check Discount at https://www.theinsightpartners.com/discount/TIPRE00005799?utm_source=OpenPR&utm_medium=Simran

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Orphan Drugs Market - By Active ingredients
1.3.2 Orphan Drugs Market - By Disease
1.3.3 Orphan Drugs Market - By End User
1.3.4 Orphan Drugs Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ORPHAN DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ORPHAN DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

Buy this Report now at https://www.theinsightpartners.com/buy/TIPRE00005799?utm_source=OpenPR&utm_medium=Simran

Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2019-2027 Orphan Drugs Market In-depth Analysis by Active Ingredients, Disease, Appication profiling CELGENE CORPORATION, Novartis AG, Takeda Pharmaceuticals, Biogen, Bristol-Myers Squibb here

News-ID: 1795868 • Views: 271

More Releases from The Insight Partners

EV Connector Market Rising Trend and Growth Strategies 2027 - Top Competitors AB …
Worldwide EV Connector Market Analysis to 2027 is a specialized and in-depth study of the EV Connector Industry with a focus on the global market trend. The report aims to provide an overview of global EV Connector Market with detailed market segmentation by product/application and geography. The global EV Connector Market is expected to witness high growth during the forecast period. The report provides key statistics on the Market status
Marijuana Drying and Curing Equipment Market Growth Prospects by Trending Techno …
The Marijuana Drying and Curing Equipment Treatment market revenue was xx.xx Million USD in 2017, grew to xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2027, with a CAGR of x.x% during 2019-2027. The "Marijuana Drying and Curing Equipment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to
Global Raising Agents Market Analysis 2019-2027 : Associated British Foods plc, …
The raising agents, or leavening agents, are substances which aid in increasing the surface of the dough or batter by releasing gases in the mixture and rendering the baked products with porous structures. Baked products are hence puffed up with increased volume and lightweight. Raising agents are essential to bakery and confectionery products including packaged and fried food products. The aeration inside can be provided using biological, mechanical or chemical
Size of the Internet of Things (IoT) sensors market worldwide from 2018 to 2027 …
The global IoT sensors market accounted to US$ 9.46 Bn in 2018 and is expected to grow at a CAGR of 23.9% during the forecast period 2019 – 2027, to account to US$ 65.79 Bn by 2027. North America was the leading IoT sensors market in 2018 and Asia-Pacific is anticipated to witness the fastest growth throughout the forecast period. Across North America, the technological advancements has led to a highly

All 5 Releases


More Releases for Orphan

Global Orphan Drug Pipeline & Regulatory Insight 2025
” Global Orphan Drug Pipeline & Regulatory Insight 2025” Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Report TOC Orphan Drugs: Regimens For Rare Diseases Drivers of Orphan Drug Commercialization 2.1 Cost
Global Orphan Drug Pipeline & Regulatory Insight 2025
” Global Orphan Drug Pipeline & Regulatory Insight 2025″ Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Orphan Drugs: Regimens For Rare Diseases Drivers of Orphan Drug Commercialization 2.1 Cost
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the
Global Orphan Drug Clinical Pipeline Insight 2022
“Global Orphan Drug Clinical Pipeline Insight 2022” report gives comprehensive insight on various clinical and non-clinical aspects associated with ongoing clinical trials of 808 orphan designated drugs across the globe. The in-depth clinical insight presented in the report helps the reader to analyze and identify the various stakeholders involved in the clinical development and commercialization of orphan designated drugs in the global market. Currently there are more than 300 orphan